Descriptive information and association between log2-EASIX-PRE and posttransplantation complications
| . | Descriptive Information . | Association . | P . |
|---|---|---|---|
| % (95% CI) . | HR (95% CI) . | ||
| Association between EASIX-PRE and posttransplantation outcomes | |||
| OS | 1.19 (1.04-1.37) | .011 | |
| 1 y | 63.1 (54.8-70.3) | ||
| 2 y | 55.4 (44.6-62.4) | ||
| NRM | 1.28 (1.08-1.53) | .004 | |
| 1 y | 26.6 (19.8-32.7) | ||
| 2 y | 28.7 (21.5-32.7) | ||
| PFS | 1.102 (0.89-1.35) | .360 | |
| 1 y | 56.0 (47.5-63.7) | ||
| 2 y | 51.8 (42.9-59.9) | ||
| CIR | 1.12 (0.82-1.54) | .450 | |
| 1 y | 18.9 (13.0-25.8) | ||
| 2 y | 22.9 (16.1-30.4) | ||
| Association between EASIX-PRE and cumulative incidences | |||
| ICU admission* | |||
| Day +180 | 18.6 (13.1-24.9) | 1.28 (1.08-1.53) | .004 |
| SOS* | |||
| Day +28 | 7.2 (3.9-11.8) | 0.79 (0.42-1.46) | .460 |
| TAM* | |||
| Day +180 | 11.4 (7.1-16.7) | 1.17 (0.90-1.51) | .230 |
| Graft failure | |||
| Day +180 | 1.2 (0.1-4.0) | 1.01 (0.51-2.26) | .841 |
| GVHD† | |||
| Grade II-IV acute GVHD at day +100 | 18.8 (13.2-25.1) | 0.99 (0.82-1.18) | .920 |
| Grade III-IV acute GVHD at day +100 | 10.3 (6.2-15.5) | 0.99 (0.79-1.25) | .970 |
| Moderate/severe chronic GVHD at 1 y | 22.1 (15-1-29.9) | 0.89 (0.72-1.11) | .320 |
| . | Descriptive Information . | Association . | P . |
|---|---|---|---|
| % (95% CI) . | HR (95% CI) . | ||
| Association between EASIX-PRE and posttransplantation outcomes | |||
| OS | 1.19 (1.04-1.37) | .011 | |
| 1 y | 63.1 (54.8-70.3) | ||
| 2 y | 55.4 (44.6-62.4) | ||
| NRM | 1.28 (1.08-1.53) | .004 | |
| 1 y | 26.6 (19.8-32.7) | ||
| 2 y | 28.7 (21.5-32.7) | ||
| PFS | 1.102 (0.89-1.35) | .360 | |
| 1 y | 56.0 (47.5-63.7) | ||
| 2 y | 51.8 (42.9-59.9) | ||
| CIR | 1.12 (0.82-1.54) | .450 | |
| 1 y | 18.9 (13.0-25.8) | ||
| 2 y | 22.9 (16.1-30.4) | ||
| Association between EASIX-PRE and cumulative incidences | |||
| ICU admission* | |||
| Day +180 | 18.6 (13.1-24.9) | 1.28 (1.08-1.53) | .004 |
| SOS* | |||
| Day +28 | 7.2 (3.9-11.8) | 0.79 (0.42-1.46) | .460 |
| TAM* | |||
| Day +180 | 11.4 (7.1-16.7) | 1.17 (0.90-1.51) | .230 |
| Graft failure | |||
| Day +180 | 1.2 (0.1-4.0) | 1.01 (0.51-2.26) | .841 |
| GVHD† | |||
| Grade II-IV acute GVHD at day +100 | 18.8 (13.2-25.1) | 0.99 (0.82-1.18) | .920 |
| Grade III-IV acute GVHD at day +100 | 10.3 (6.2-15.5) | 0.99 (0.79-1.25) | .970 |
| Moderate/severe chronic GVHD at 1 y | 22.1 (15-1-29.9) | 0.89 (0.72-1.11) | .320 |